Remicade (infliximab) - J&J
Taltz (ixekizumab) - Eli Lilly
Bimzelx (bimekizumab-bkzx) - UCB
Cimzia (certolizumab pegol) - Astellas, UCB
Humira (adalimumab) - AbbVie
Tremfya (guselkumab) - J&J
Cosentyx (secukinumab) - Novartis
Stelara (ustekinumab) - J&J
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
Enbrel (etanercept) - Pfizer, Amgen
https://s3.eu-central-1.amazonaws.com/m-anage.com.storage.eadv/abstracts_symposium_2026/61965.pdf
 
İlgen Ertam Sağduyu1; Aslıhan Özel 1; Ayda Acar2; Nilay Duman1; Işıl Karaarslan1, İdil Ünal1
 
May 13, 2026
 
Prev Next